Success Metrics

Clinical Success Rate

60.0%

Based on 3 completed trials

Completion Rate

60%(3/5)

Active Trials

0(0%)

Results Posted

67%(2 trials)

Terminated

2(33%)

Phase Distribution

Ph not_applicable

17%

Ph phase_4

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 4Post-market surveillance

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(2)

Other(1)

Detailed Status

Completed3

Terminated2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

60.0%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (50.0%)

N/A1 (50.0%)

Trials by Status

terminated233%

completed350%

unknown117%

Recent Activity

0 active trials

Showing 5 of 6

completed

Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.

NCT04855422

terminatednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT04855422

Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.

Completed

NCT04318587Not Applicable

Assessment of Donor Derived Cell Free DNA and Utility in Lung Transplantation

Terminated

NCT05747053

Personalization of Immunosuppressive Treatment for Organ Transplant Recipients

Terminated

NCT04177095Phase 4

Immune Monitoring to Facilitate Belatacept Monotherapy

Completed

NCT04601155

Transition of Renal Patients Using AlloSure Into Community Kidney Care

Completed

NCT04566055

Assessing AlloSure Dd-cfDNA Monitoring Insights of Renal Allografts With Longitudinal Surveillance

Unknown

All 6 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 6